Dr. Paul Nelson
Add to your Care-Team
Dr. Paul Nelson
Dr. Paul Nelson
Suite 300, IN
I specialize in
I have been in practice
My answers and insights have
Helped 20 people
Here are kind words from others
This Thanksgiving, I wanted to share my appreciation for all that you do! Thank you, doctor! :)
I am located at
8333 Naab Rd.
Suite 300 , IN 46260
13430 North Meridian Street
Carmel , IN 46032
I was educated and trained at
Medical / Graduate School
University of Kansas School of Medicine
When will real benefits for minority patients be realized with A2-->B transplants?
Transplantation., Jun;89(11):1310-1 (2010)
A new role for the virtual crossmatch in kidney allograft reuse.
Transplantation., Mar;89(6):764-5 (2010)
Sharing kidneys across donor-service area boundaries with sensitized candidates can be influenced by HLA C.
Clin Transplant., 24(1):56-61 (2010 Jan-Feb)
Clinical management of discolored teeth.
Gen Dent., May;56(3):294-300; quiz 301-4 (2008)
Tooth whitening: a clinical review.
Tex Dent J., Jul;125(7):602-13 (2008)
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients.
Am. J. Transplant., May;7(5):1181-4 (2007)
Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate.
Clin Transpl., 127-33 (2004)
Organ donation and utilization, 1995-2004: entering the collaborative era.
Am. J. Transplant., 6(5 Pt 2):1101-10 (2006)
Is trauma centre care helpful for less severely injured patients?
Injury., Nov;36(11):1293-7 (2005)
Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients.
Transplantation., Jul;80(1):75-80 (2005)
ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney.
Clin Transplant., 18 Suppl 12:55-60 (2004)
The risk for Chagas' disease in the Midwestern United States organ donor population is low.
Clin Transplant., 18 Suppl 12:12-5 (2004)
Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching.
Transplantation., Dec;66(12):1827-32 (1998)
Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys.
Transplantation., Dec;66(12):1714-7 (1998)
Influence of the Rh (D) blood group system on graft survival in renal transplantation.
Transplantation., Feb;65(4):588-92 (1998)
Ten-year experience in transplantation of A2 kidneys into B and O recipients.
Transplantation., Jan;65(2):256-60 (1998)
HLA-DR and DQ typing by polymerase chain reaction using sequence-specific primer mixes reduces the incidence of phenotypic homozygosity (blanks) over serology.
Transplantation., Dec;62(12):1819-24 (1996)
Improved graft survival in cadaveric renal retransplantation by flow crossmatching.
Arch Surg., Jun;131(6):599-603 (1996)
Stratification and successful transplantation of patients awaiting ABO-incompatible (A2 into B and O) transplantation by A-isoagglutinin-titer phenogroup.
Transplant. Proc., Feb;28(1):221-3 (1996)
Allocation of kidneys to Afro-American patients is proportional to wait-list composition.
Transplant. Proc., Feb;28(1):219-20 (1996)
Do African-Americans wait longer for a kidney because of HLA class I antibody specificities and panel-reactive antibody sensitization?
Transplant. Proc., Feb;28(1):157-9 (1996)
A seven year experience with kidney transplantation for pediatric end stage renal disease.
Mo Med., Jan;91(1):33-7 (1994)
Incidence of a positive final antiglobulin (AHG) T-cell crossmatch in patients waiting for cadaveric renal transplantation is not influenced by race of recipient.
Transplant. Proc., Dec;25(6):3273-4 (1993)
Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocation.
Transplant. Proc., Dec;25(6):3060-3 (1993)
Clinical relevance of a positive B-cell crossmatch on renal transplantation: a multi-transplant center evaluation.
Transplant. Proc., Feb;25(1 Pt 1):247-50 (1993)
Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation.
Transplant. Proc., Feb;25(1 Pt 2):1469-71 (1993)
Current experience with renal transplantation across the ABO blood group barrier.
Transplant. Proc., Dec;24(6):2527-9 (1992)
Influence of race, PRA level, and gender on the incidence of a positive donor-specific preliminary T cell crossmatch.
Transplant. Proc., Dec;24(6):2517-8 (1992)
Influence of HLA and race on long-term cadaveric renal transplantation.
Transplant. Proc., Dec;24(6):2451-3 (1992)
A prospective evaluation of plasma-TFE and expanded PTFE grafts for routine and early use as vascular access during hemodialysis.
Ann. Surg., Nov;216(5):596-9 (1992)
Current experience with renal transplantation across the ABO barrier.
Am. J. Surg., Nov;164(5):541-4; discussion 544-5 (1992)
High incidence of cardiopulmonary complications associated with implantation of adrenal medullary tissue into the caudate nucleus in patients with advanced neurologic disease.
Crit. Care Med., Feb;19(2):181-6 (1991)
Elective conversion from cyclosporine to azathioprine in sensitized patients following cadaveric renal transplantation.
Am. J. Kidney Dis., Feb;15(2):137-40 (1990)
Mycotic thoracic aortic aneurysm producing vertebral body destruction and paraplegia: case report.
Paraplegia., Oct;27(5):406-9 (1989)
Successful transplantation of blood group A2 kidneys into non-A recipients.
Transplantation., Feb;45(2):316-9 (1988)
Transplantation of blood group A2 cadaveric kidneys into O and B recipients.
ANNA J., Dec;15(6):395-6 (1987)
Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
Transplant. Proc., Dec;16(6):1492-3 (1984)
Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection.
Transplantation., Dec;38(6):695-701 (1984)
Surg Gynecol Obstet., Sep;159(3):297-308 (1984)
The use of local allograft irradiation following renal transplantation.
Int. J. Radiat. Oncol. Biol. Phys., Jul;10(7):987-90 (1984)
Unsuspected donor pseudomonas infection causing arterial disruption after renal transplantation.
Transplantation., Mar;37(3):313-4 (1984)
Antithymocyte globulin as the primary treatment for renal allograft rejection.
Transplantation., Nov;36(5):587-9 (1983)
Elective splenectomy in children: indications and operative approach.
Tex Med., Aug;78(8):47-9 (1982)
Is staging laparotomy for Hodgkin's disease still justified?
Am. J. Surg., Mar;143(3):288-92 (1982)
A comparative review of cylindrical inlay facet fusions for scoliosis.
South. Med. J., Feb;70(2):189-90 (1977)
An unusual case of tardy median nerve palsy.
Am J Orthop., Nov;9(11):243-5 (1967)
Dr. Paul Nelson M